Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review
Clostridium difficile infections are a global clinical concern and are one of the leading causes of nosocomial outbreaks. Preventing these infections has benefited from multidisciplinary infection control strategies and new antibiotics, but the problem persists. Probiotics are effective in preventin...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-04-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | http://www.mdpi.com/2079-6382/4/2/160 |
id |
doaj-a1b56589d18b41c5a13ab677d8c0bc78 |
---|---|
record_format |
Article |
spelling |
doaj-a1b56589d18b41c5a13ab677d8c0bc782020-11-25T01:04:41ZengMDPI AGAntibiotics2079-63822015-04-014216017810.3390/antibiotics4020160antibiotics4020160Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic ReviewLynne V. McFarland0Department of Medicinal Chemistry, University of Washington, VA Puget Sound Healthcare System, 1660 S. Columbian Way, S-152, Seattle, WA 98108, USAClostridium difficile infections are a global clinical concern and are one of the leading causes of nosocomial outbreaks. Preventing these infections has benefited from multidisciplinary infection control strategies and new antibiotics, but the problem persists. Probiotics are effective in preventing antibiotic-associated diarrhea and may also be a beneficial strategy for C. difficile infections, but randomized controlled trials are scarce. This meta-analysis pools 21 randomized, controlled trials for primary prevention of C. difficile infections (CDI) and four trials for secondary prevention of C. difficile recurrences and assesses the efficacy of specific probiotic strains. Four probiotics significantly improved primary CDI prevention: (Saccharomyces boulardii, Lactobacillus casei DN114001, a mixture of L. acidophilus and Bifidobacterium bifidum, and a mixture of L. acidophilus, L. casei and L. rhamnosus). None of the tested probiotics significantly improved secondary prevention of CDI. More confirmatory randomized trials are needed to establish if probiotics are useful for preventing C. difficile infections. vhttp://www.mdpi.com/2079-6382/4/2/160probioticsclostridium difficile infectionsdiarrheameta-analysisv |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Lynne V. McFarland |
spellingShingle |
Lynne V. McFarland Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review Antibiotics probiotics clostridium difficile infections diarrhea meta-analysisv |
author_facet |
Lynne V. McFarland |
author_sort |
Lynne V. McFarland |
title |
Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review |
title_short |
Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review |
title_full |
Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review |
title_fullStr |
Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review |
title_full_unstemmed |
Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review |
title_sort |
probiotics for the primary and secondary prevention of c. difficile infections: a meta-analysis and systematic review |
publisher |
MDPI AG |
series |
Antibiotics |
issn |
2079-6382 |
publishDate |
2015-04-01 |
description |
Clostridium difficile infections are a global clinical concern and are one of the leading causes of nosocomial outbreaks. Preventing these infections has benefited from multidisciplinary infection control strategies and new antibiotics, but the problem persists. Probiotics are effective in preventing antibiotic-associated diarrhea and may also be a beneficial strategy for C. difficile infections, but randomized controlled trials are scarce. This meta-analysis pools 21 randomized, controlled trials for primary prevention of C. difficile infections (CDI) and four trials for secondary prevention of C. difficile recurrences and assesses the efficacy of specific probiotic strains. Four probiotics significantly improved primary CDI prevention: (Saccharomyces boulardii, Lactobacillus casei DN114001, a mixture of L. acidophilus and Bifidobacterium bifidum, and a mixture of L. acidophilus, L. casei and L. rhamnosus). None of the tested probiotics significantly improved secondary prevention of CDI. More confirmatory randomized trials are needed to establish if probiotics are useful for preventing C. difficile infections. v |
topic |
probiotics clostridium difficile infections diarrhea meta-analysisv |
url |
http://www.mdpi.com/2079-6382/4/2/160 |
work_keys_str_mv |
AT lynnevmcfarland probioticsfortheprimaryandsecondarypreventionofcdifficileinfectionsametaanalysisandsystematicreview |
_version_ |
1725196746998415360 |